Skip to main content
. 2019 May 7;25:3374–3389. doi: 10.12659/MSM.914085

Figure 11.

Figure 11

The RFS of 4.1N in BC. (A) High mRNA level of 4.1N was not associated with longer RFS in all BC patients. (B, C) High mRNA level of 4.1N was not associated with longer RFS both in ER-positive and ER-negative BC patients. (D–G) High mRNA level of 4.1N was not associated with longer RFS in basal-like, luminal A, luminal B, or HER2+ BC patients.